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1. Introduction 
The present knowledge of the biosynthesis of ribo- 
flavin (5) is outlined in fig. 1. The direct precursor of 
riboflavin, 6,7dimethyl-8-ribityllumazine (4), was iso- 
lated from Eremothecium ash&ii [l] and from a num- 
ber of other microorganisms [2,3]. 5-Amino_2,6dihy- 
droxy4ribitylaminopyrimidine (3) and 2,5-diamino- 
6-hydroxy4ribitylaminopyrimidine (2) were detected 
in the culture media of riboflavin auxotrophs of Sac- 
charomyces cerevisiue [3,4]. The involvement of a pu- 
rine precursor in riboflavin biosynthesis has been 
demonstrated repeatedly [5,6]. Recently Bather and 
Lingens have demonstrated by experiments with a 
purine auxotroph of Aerobacter aerogenes, that a pur- 
ine compound at the biosynthetic level of guanine (1) 
is used [7]. Baugh and Krumdieck obtained similar 
results with a wild strain of Colynebacterium sp. in- 
hibited by decoyinine [8]. 
The present paper is concerned with the detection 
of 6-hydroxy-2,4,5&iaminopyrimidine (6) in ribofla- 
vin auxotrophs of S. cerevisiae and with the comple- 
2. Materials and methods 
2-Amino-6,7dimethyWhydroxypteridine was a 
gift of Prof. Pfleiderer, Konstanz. 2-Amino+hydroxy- 
pteridine was synthesized [9]. 
Riboflavin auxotrophs N 179 and N 2 13 were iso- 
lated after treatment of S. cerevisiae S 285 C with l- 
methyl-3-nitro-1-nitrosoguanidine ssentially as des- 
cribed by Oltmanns and Lingens [ 10 J. 
S. cerevisiae N 179 was grown in a 100 1 batch fer- 
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mentor in minimal medium [lo] supplemented with 
yeast extract (Difco) (1.5 g/l), peptone (Difco) (1.5 
g/l) and riboflavin (10 mdl). The cells were harvested 
and resuspended in minimal medium supplemented 
with diacetyl(O.8 g/l) or glyoxaI(O.6 g/l). After 24 hr, 
the suspension was centrifuged. The supernatant was 
passed through a column of magnesium silicate 
(Woelm). The column was washed with water and e- 
luted with acetone - 2 N ammonia (2: 1, v/v). The eluate 
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Fig. 1. Biosynthesis of riboflavin and genetic blocks of S. cere- 
visiae mutants. 
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was evaporated to dryness in vacua. From the residue 
pteridines were isolated by chromatography on Dowex 
50 W X 8 (elution with HCl). The compounds were re- 
crystallized from water. 
Complementation tests were performed as described 
elsewhere [ 1 l] . 
3. Results 
We have found previously that the identification 
of pyrimidine intermediates of riboflavin biosynthesis 
is greatly simplified by condensation of these labile 
substances with glyoxal or diacetyl prior to isolation 
[3,4]. By application of this technique we now were 
able to demonstrate the formation of 6-hydroxy-2,4,5- 
triaminopyrimidine (6) in two riboflavin auxotrophs. 
A blue fluorescent compound is formed when mu- 
tant N 179 is incubated in minimal medium containing 
diacetyl. This compound was isolated as described in 
Methods. We obtained 1.5 mg of colourless micro- 
crystals from 100 1 of medium. They could be iden- 
tified as 2-amino-6,7dimethyl4hydroxypteridine (7) 
by means of UV- and IR-spectrometry and by thin-lay- 
er chromatography in 5 solvent systems. 
In a similar experiment, glyoxal was added to the 
accumulation medium instead of diacetyl. We isolated 
2-amino4hydroxypteridine (8) (0.4 mg/ 100 I), which 
was identified by the same methods. 
None of the pteridines described could be isolated 
from fermentations without either glyoxal or diacetyl. 
We conclude from these results, that the mutant pro- 
duces 6-hydroxy-2,4,5-triaminopyrimidine (6) (fig. 2). 
Experiments with mutant N 2 13 gave the same results. 
In previous experiments a minimum number of 6 
riboflavin genes (rib, - rib, corresponding to comple- 
mentation groups I-VI) was detected in S. cerevisiae 
[ 1 I] (see fig. 1). We found that mutants N 179 and 
N 213 complement with mutants of complementation 
groups I-V (table 1). We have not tested complemen- 
tation group VI (accumulating 6,7dimethyl-8-ribityl- 
lumazine) for technical reasons. Probably the mutants 
N 179 and N 2 13 (complementation group VII) repre- 
sent a new gene (rib) rather than a case of intragenic 
complementation. 
OH 
Fig. 2. Condensation of 6-hydroxy-2,4,Wriaminopyrimidine 
with diacetyl and glyoxal, respectively. 
Table 1 
Complementation of riboflavin auxotrophs of S. cerevisiae; 
C.G. = complementation group, + = growth of diploids on mi- 
mal medium, s = slow growth. 
Gene ‘b7 
C.G. VII 
mutant N 179 N 213 
rib1 
11% 1 
rib2 
rib3 
rib3 
rib4 
rib4 
rib4 
rib5 
rib5 
I HK 761 
I HK 851 
II HK 857 
III HK 693 
III HK 882 
IV HK 829 
IV HK 871 
IV HK 890 
V HK 750 
V HK 873 
+ 
S 
+ 
+ 
S 
+ 
S 
+ 
S 
+ 
S 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
4. Discussion 
From the formation of 2,5diamino-6-hydroxy4 
ribitylaminopyrimidine (2) in riboflavin auxotrophs of 
S. cerevisiae, Bather and Lingens concluded that the 
biosynthesis of riboflavin starts from a derivative of 
guanine rather than from another purine compound 
[4]. This hypothesis was confirmed by studies on a pu- 
rine auxotroph of A. aerogenes [7;. It receives further 
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support by the detection of 6-hydroxy-2,4,5-triamino- 
pyrimidine in riboflavin auxotrophs of 5’. cereuisiue. 
The mutants described in this paper are probably 
defective in the conversion of the guanine precursor 
(1) to 2,5diamino-6-hydroxyllribitylaminopyrimidi- 
ne (2). The question still remains, whether 6-hydroxy- 
2,4,5_triaminopyrimidine is a true intermediate of ri- 
boflavin biosynthesis or a secondary product originat- 
ing from the decomposition of an intermediate, espe- 
cially by loss of a ribose moiety. In particular, our 
findings do not exclude the possibility, that the bio- 
synthesis of 2,5diamino-6_hydroxy4ribitylamino- 
pyrimidine proceeds via the same intermediates as the 
biosynthesis of dihydroneopterinephosphate [ 121. 
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